StockData
CHENYSEServices-Home Health Care ServicesFiscal year ends December 31

CHEMED CORP

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026
$508.29−4.09 (-0.80%)

Close on Oct 19, 2026

Market cap
$6.71B
P/E (TTM)
25.5
Dividend yield
0.43%

CHEMED CORP revenue by segment

By business segment

RevenueTTM Q2 26TTM Q1 26TTM Q4 25TTM Q3 25TTM Q2 25TTM Q1 25TTM Q4 24TTM Q3 24TTM Q2 24TTM Q1 24TTM Q4 23TTM Q3 23% of revenueYoY
VITAS [Member]$1.69B$1.64B$1.63B$1.62B$1.61B$1.58B$1.53B$2.44B$2.04B$1.67B$1.32B$1.20B65.1%+5.2%
Roto-Rooter [Member]$905.14M$897.83M$899.88M$908.28M$905.90M$904.63M$900.31M$907.24M$923.27M$934.90M$949.35M$952.03M34.9%-0.1%
Operating incomeTTM Q2 26TTM Q1 26TTM Q4 25TTM Q3 25TTM Q2 25TTM Q1 25TTM Q4 24TTM Q3 24TTM Q2 24TTM Q1 24TTM Q4 23TTM Q3 23YoY
VITAS [Member]$275.25M$246.62M$246.94M$249.76M$259.09M$273.62M$263.97M–––––+6.2%
Roto-Rooter [Member]$154.36M$154.85M$160.83M$174.22M$181.46M$192.88M$194.52M–––––-14.9%

By product or service

RevenueTTM Q2 26TTM Q1 26TTM Q4 25TTM Q3 25TTM Q2 25TTM Q1 25TTM Q4 24TTM Q3 24TTM Q2 24TTM Q1 24TTM Q4 23TTM Q3 23% of revenueYoY
All Other Revenue- Self-pay, Respite Care, Etc. [Member]––––––$19.46M$17.74M$16.22M$14.64M$13.58M$12.71M––
Continuous Care [Member]––––––$99.75M$96.92M$93.15M$89.90M$85.67M$82.34M––
Care Services Total [Member]––––––$1.55B$1.49B$1.43B$1.38B$1.33B$1.29B––
Inpatient Care [Member]––––––$120.60M$117.40M$115.30M$113.63M$112.42M$110.96M––
Routine Home Care [Member]––––––$1.33B$1.27B$1.22B$1.17B$1.14B$1.10B––

By region

From the segment and revenue-disaggregation notes of Chemed's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.